title: An alternative agent for radial arterial graft spasm: application of topical iloprost.
abstract: OBJECTIVE
  This study is planned bringing about a new choice for the prophylaxis of RA spasm which is topical iloprost and compares its efficacy with papaverine and diltiazem.
  
  
  METHODS
  Twenty eight CABG patients with RA grafts were categorized into four groups by taking into account the topical vasodilator (papaverine, diltiazem, iloprost and saline) that was utilized during harvesting. Arterial segments were separated into four rings and were than soaked with KCL, norepinephrine, phenylephrine and serotonin. Then, acetylcholine was given to induce relaxation and the preparations were put to rest for 10 minute.
  
  
  RESULTS
  The contraction response achieved by the vasoreactive agents was most effectively inhibited by papaverine. The effectiveness of the response obtained by iloprost was similar to that of papaverine and significantly stronger than that of diltiazem. Especially at high vasoreactive substance concentrations, diltiazem had a contraction close to that of the control while the protective effect was weaker than those of papaverine and iloprost.
  
  
  CONCLUSIONS
  Iloprost can be recommended as a strong alternative to the topical agents used for preventing arterial graft spasm.
authors.affiliation: Department of Cardiovascular Surgery, Medical School of Eskisehir Osmangazi University, Turkey.
authors.forename: Coskun
authors.initials: C
authors.lastname: Ozdemir
authors.forename: Murat
authors.initials: M
authors.lastname: Ikizler
authors.forename: Yavuz
authors.initials: Y
authors.lastname: Besogul
authors.forename: Atalay
authors.initials: A
authors.lastname: Karakaya
authors.forename: Basar
authors.initials: B
authors.lastname: Sirmagul
mesh_terms: D000287:Administration, Topical; D000368:Aged; D001157:Arterial Occlusive Diseases / Q000150:complications / Q000517:prevention & control*; D001026:Coronary Artery Bypass; D004110:Diltiazem / Q000008:administration & dosage; D004305:Dose-Response Relationship, Drug; D005260:Female; D006083:Graft Occlusion, Vascular / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D016285:Iloprost / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D009638:Norepinephrine / Q000494:pharmacology; D010208:Papaverine / Q000008:administration & dosage; D010656:Phenylephrine / Q000494:pharmacology; D011189:Potassium Chloride / Q000494:pharmacology; D017534:Radial Artery / Q000187:drug effects* / Q000637:transplantation; D012701:Serotonin / Q000494:pharmacology; D013035:Spasm / Q000150:complications / Q000517:prevention & control*; D020858:Tissue and Organ Harvesting / Q000379:methods*; D016896:Treatment Outcome; D014661:Vasoconstriction / Q000187:drug effects*; D014662:Vasoconstrictor Agents / Q000494:pharmacology; D014665:Vasodilator Agents / Q000008:administration & dosage*
chemical_list: D014662:Vasoconstrictor Agents; D014665:Vasodilator Agents; D010656:Phenylephrine; D012701:Serotonin; D011189:Potassium Chloride; D010208:Papaverine; D004110:Diltiazem; D016285:Iloprost; D009638:Norepinephrine